Increased capital investment and higher turnover rates have encouraged the implementation of deep learning technologies to accelerate the drug discovery process. The early stage diagnostic capabilities of such technologies have also emerged as important drivers for their adoption.
Roots Analysis is pleased to announce the publication of a recent study titled “Deep Learning in Drug Discovery and Deep Learning in the Diagnostic Market (2nd Edition).”
To request a quote for this report, see:
https://www.rootsanaliss.com/reports/deep-learning-in-drug-discovery-market/request-quote.html
This report features extensive research into the current market environment and the potential future potential of the deep learning solutions market within the healthcare domain. The report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. Among other factors, the report includes:
1. The executive summary of insights photographed during our study provides a high level of view on the current state of the deep learning market for drug discovery and diagnosis, as well as the possibility of mid- to long-term evolution.
2. A general overview of the big data revolution in the healthcare industry and information on artificial intelligence, machine learning, and deep learning algorithms.
3. A detailed assessment of the market environment of over 70 companies providing deep learning techniques/services for drug discovery, based on several relevant parameters.
4. A detailed assessment of the market environment of over 130 companies providing deep learning technology/services for diagnostics based on several relevant parameters.
5. Elaborate profiles of key players who develop technologies particularly related to deep learning, particularly for drug discovery and diagnosis, and provide services related to deep learning.
6. Qualitative analysis highlighting five competitive advantages that are popular in deep learning areas.
7. Analysis of completed and ongoing clinical trials related to deep learning based on several relevant parameters.
8. A detailed analysis of the various investments made by players engaged in this domain during the period 2019-2022 based on several related parameters.
9. Analysis of startups/small players (with fewer than 50 employees established since 2015) working in the deep learning market focused on drug discovery and diagnosis.
10. Current Assessment of Industry Players/Elaborate valuation analysis of companies involved in deep learning of drug discovery and diagnostic markets based on our proprietary multivariable dependent valuation model for estimating net assets.
To request a sample copy/brochure of this report, please see
https://www.rootsanaliss.com/reports/deep-learning-in-drug-discovery-market/request-sample.html
Detailed market forecasts (listed below) featuring an analysis of current and forecast future opportunities across key market segments
A. Treatment Area
1. Tumor disorders
2. Infectious diseases
3. Neuropathy
4. Immune disorders
5. Endocrine disorders
6. Cardiovascular Disorders
7. Respiratory disorders
8. Ophthalmic disorders
9. Musculoskeletal disorders
10. Other obstacles
B. Major Geographic Areas
1. North America
2. Europe
3. Asia Pacific
4. The rest of the world
Complete Report Description + Research Methodology + Content Table + View Infographics Here:
https://www.rootsanaliss.com/reports/deep-learning-in-drug-discovery-market/156.html
Major companies/organizations featured in the report
1. Aegicare
2. AiforiaTechnologies
3. Arjigen
4. Burg
5. Google
6. Huawei
7. merit
8. nference
9. Nvidia
10. Orkin
11. Phenomic AI
12. Pixel AI
Contact details
Gaurav Chaudhary
Email: gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com
About root analysis
Roots Analysis is the global leader in Pharma/Biotech market research. Working with over 750 clients around the world, including Fortune 500 companies, startups, academia, venture capitalists and strategic investors, we have provided a highly analytical/data-driven perspective to our network of over 450,000 senior industry stakeholders seeking reliable market insights for over a decade. All reports we provide are structured to help our readers develop a thorough perspective on a particular subject. Apart from writing reports on identified areas, we provide custom research/consulting services to serve our clients in the best possible way.
This release has been published on OpenPR.
